Daily Research Digest
Saturday, October 24, 2026 · 3 min read
Top finding
A randomized clinical trial (RCT) testing emotion-focused behavioral weight loss treatment for adolescents addresses a practical problem: family-based behavioral treatment (FBT) tends to lose efficacy in adolescence, a period when young people are gaining autonomy and still developing emotion regulation skills. The trial's design targets that gap by building emotional skills directly into the weight intervention rather than relying on parental control of eating and activity alone. The sample size was not reported in the extracted data, so the strength of the result should be read cautiously until the full paper is reviewed. Adolescent weight management is an area where effect sizes from single trials often shrink on replication, so this should be treated as a promising direction rather than an established approach. [1]
What to do this week
Educational recap based on this week’s evidence. Not medical advice.
An internet-delivered behavioral self-monitoring RCT in older widowed adults tested whether structured tracking of health behaviors could reduce depressive symptoms after bereavement. Behavioral self-monitoring is a low-cost, scalable approach, and the study focuses on a population with substantial change in routine health behaviors after spousal loss. Sample size was not captured in the extracted data. [2]
A systematic review and meta-analysis examined gestational exposure to endocrine-disrupting chemicals and small vulnerable newborns. The authors describe epidemiological findings as inconsistent across studies, and the pooled analysis reflects that heterogeneity, so the association should be considered unsettled. Sample size was not captured in the extracted data. [3]
A randomized trial of fecal microbiota transplantation (FMT) in obesity and type 2 diabetes found that gut virome remodeling, including virus-bacteria co-variation, was associated with metabolic response beyond bacterial changes alone. This is mechanistic and association-level evidence, not proof that virome shifts drive the metabolic benefit. Sample size was not captured in the extracted data. [4]
Get the weekly digest in your inbox
No spam. Just evidence.
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.